215 Euston Road
London NW12BE
United Kingdom
https://www.synconaltd.com
Sector(s): Financial Services
Industry: Asset Management
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Thomas Henderson | Co-Founder & Non-Exec. Director | N/A | N/A | 1966 |
Dr. Martin Patrick Murphy Ph.D. | Chief Exec. Officer | N/A | N/A | 1968 |
Mr. John McDonald | Co-Founder | N/A | N/A | 1965 |
Mr. Rolf Kristian Berndtson Soderstrom ACA, BA | Chief Financial Officer | N/A | N/A | 1966 |
Dr. Christopher J. Hollowood Ph.D. | CIO & Managing Partner of Syncona Investment Management Ltd. | N/A | N/A | 1975 |
Ms. Annabel Clay | Head of Investor Relations | N/A | N/A | N/A |
Mr. Andrew Cossar | Gen. Counsel of Syncona Investment Management Ltd. | N/A | N/A | N/A |
Ms. Fenella Dernie | Exec. Officer | N/A | N/A | N/A |
Ms. Nikki Padden Ph.D. | Head of Fin. at Syncona Investment Management Ltd. | N/A | N/A | N/A |
Ms. Magdalena Jonikas | Partner of Syncona Investment Management Limited | N/A | N/A | N/A |
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
Syncona Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.